development operations. Administrative expenses increased by Baht 8 million due mainly to loss on exchange rate. Share of loss from investment in associate increased by Baht 6 million and this relates to the
gains from exchange rate. ,Interest income ,income tax refund ,Bad debt refund ,and Gain on debt restructuring. In Q2-2017 Other income are increase amount of 5 Million Baht equivalent 1,701% Because
/2017 amounted 111.00 million baht increased by 14.64 million baht or 15.19% from 96.36 million baht in Q3/2016 due to the increase of interest rate. For the separate company financial statement, the
profit 25.35 44.08 31.23 -12.85 -29.15 5.88 23.20 Profit (Loss) from exchange rate 0.12 1.19 0.54 -0.65 -54.62 0.42 350.00 Other Income 1.26 2.13 2.1 -0.03 -1.41 0.84 66.67 Gain from bargain purchase 33.64
) (100) (50) - 50 100 Q 1 2 0 1 9 Q 1 2 0 1 8 Statements of Cash Flows Dividend payment The company had the dividend payment policy stipulated that dividends shall be paid at the rate of not less than 40
results for the six-month period of 2019, change of rate more than 20 percent Dear Director and Manager The Stock Exchange of Thailand According to the resolution of the Board of Directors of DOD Biotech
International Hospital” to the Group. The finance costs decreased in the amount of Baht 5.9 million or 15.3% which in line with the management of interest rate of long-term debts. - Income tax for Q1/2018 in the
. Administrative expenses decreased by Baht 7 million due mainly to a decrease in loss on exchange rate and repair & maintenance expenses. Share of loss from investment in associates decreased by Baht 20 million
an decreasing of 46.51% from the total gross profit of 3rd quarter of year 2017 at Baht 159.97 million. The gross profit rate was decreasing from 14.76% to 8.39%. The profit detail was as follow; The
of pipes for the quarter 3/2019 was 87.82% of income. The cost per income rate decreased when compared to quarter 3/2018 which was 93.63 percent of income. The major reason was the cost of raw